Home » News
26 Oct 2018

Researchers from Queen’s University Belfast and the University of Leeds, as part of a pan-European partnership called the European Cancer Concord (ECC) ®, have won the prestigious 2018 European Health Award.

This award honours initiatives that help tackle some of Europe’s most pressing health challenges.


The award-winning project, entitled ‘The European Cancer Patient’s Bill of Rights: A Catalyst for Change and an empowerment tool for cancer patients across Europe’ involves an equal partnership between cancer patients, healthcare professionals and cancer researchers.

Professor Mark Lawler, Vice President of the European Cancer Concord (ECC), today received the award on behalf of ECCO during the opening ceremony of the European Health Forum Gastein, the premier European Health Policy Conference and an official event of the Austrian European Council Presidency. 

25 Jul 2018

Susan Richman from the Leeds Institute of Cancer and Pathology obtained £1120 from the Medical Research Council (MRC)  to fund a stand  at the MRC’s Festival of Medical Research.  The stand titled, ‘So, just what is personalised Medicine?’ was split into three sections, with the first aiming to bust the stigma around bowel cancer screening, incorporating a game and a competition.

1 Dec 2017

European Alliance for Personalised Medicine Inaugural Congress, Belfast

“Personalising your Health – a global imperative”

27th-30th November 2017

Over six hundred delegates attended the inaugural event from across EU member states and held in conjunction with the Estonian presidency. S:CORT professors Tim Maughan and Richard Sullivan and Lisa Wilde from BC-UK all took part in the acclaimed session; “left behind and burnt out? The lived experience of the molecularly unstratified patient and stratified medicine researchers.” During the session both S:CORT and FOCUS4 were given as exemplars of the progress in precision medicine research. Posters were also presented during breakout sessions representing our work in the fields of; patient and public involvement, health economics and tumour heterogeneity.

The event was also attended by policy makers, patient groups and industry representatives from across Europe helping to achieve the congress objective to put personalised medicine at the forefront of European decision making on health.

31 May 2017

Through new research led by Queen’s University Belfast we have discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.

31 Jul 2016

In a novel public engagement event designed to showcase the potential benefits of personalised cancer medicine, Almac Diagnosticsa leading personalised medicine company, opened its doors to cancer patients in Northern Ireland enabling them to see “Science in Action” and how partnerships between industry and academia have the potential to benefit patients suffering from the disease. 

31 Jan 2016

On January 13th 2016, the Consortium Management Group of S:CORT met at the University of  Leeds. As part of our outreach strategy, a public engagement event “Stratified Medicine – Providing Hope for Cancer Patients” took place at the Thackray Medical Museum. Speakers included Alf Oliver who related his experiences as a bowel cancer survivor and Prof  Mark Lawler (Public Engagement Lead) who gave a presentation entitled “Personalising Treatment for Cancer Patients”.

previous 1 2

  • Oxford University King's College London Queen's University Belfast
  • University of Leeds University of Aberdeen Sanger Institute
  • University College London University of Birmingham Partnering to Advance Human Health